Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrillation
A Randomized Trial to Investigate the Significance of Complete Versus Incomplete Electrical Isolation of Pulmonary Veins by Radiofrequency-induced Linear Lesions
Sponsor: Abbott Medical Devices
This NA trial investigates Atrial Fibrillation and is currently completed. Abbott Medical Devices leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Feb 2019 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2018 [monthly]
Completed NA
First recorded
Feb 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- Atrial Fibrillation Network
- Biosense Webster, Inc.
- C. R. Bard
- Medtronic
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Hamburg, Germany
- • Münster, Germany